The PNEUMONIA Times
Pfizer partners with South Africa's Biovac Institute to produce pneumonia vaccine
Global pharmaceutical company (Pfizer) and South Africa's Biovac Institute has decided to work together to produce a potentially life-saving pneumonia vaccine for children.
According to the World Health Organisation, pneumonia is the leading infectious cause of death among infants. In 2013, it was estimated that pneumonia killed 935,000 children under the age of 5.
It is a five-year process, whereby they will start with packaging and labelling. After which, it will be followed with formulating the vaccines at Biovac’s Pinelands facility. A locally made vaccine was expected by 2020, with sales initially confined to the state sector. By 2020, Biovac hopes to supply the peneumonia vaccine across Africa.
References: http://www.channelnewsasia.com/news/health/pfizer-partners-with-sout/2235374.html